ExploreWatchlistsPricing
  1. JP-listed companies
  2. J Frontier Co.,Ltd.
  3. Financials
  4. Cash and cash equivalents

J Frontier Co.,Ltd. (2934)

Market cap
¥8.1B
P/E ratio
79.4x
J-Frontier develops and sells health supplements and pharmaceuticals while operating SOKUYAKU, a medical platform for online consultations and prescription delivery.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
May 31, 20252,170+19.67%
May 31, 20241,813+9.99%
May 31, 20231,648-44.24%
May 31, 20222,956+80.46%
May 31, 20211,638+80.42%
May 31, 2020908-4.73%
May 31, 2019953

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat